Diligent Investors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-3,615
Closed -$334K 226
2019
Q2
$334K Sell
3,615
-50
-1% -$4.75K 0.17% 147
2019
Q1
$346K Sell
3,665
-150
-4% -$13.1K 0.2% 128
2018
Q4
$245K Hold
3,815
0.16% 146
2018
Q3
$341K Hold
3,815
0.19% 136
2018
Q2
$303K Buy
3,815
+75
+2% +$6.23K 0.18% 138
2018
Q1
$334K Buy
3,740
+300
+9% +$28.8K 0.2% 130
2017
Q4
$359K Buy
3,440
+200
+6% +$22.6K 0.23% 125
2017
Q3
$472K Hold
3,240
0.34% 80
2017
Q2
$421K Hold
3,240
0.3% 88
2017
Q1
$403K Hold
3,240
0.31% 79
2016
Q4
$375K Hold
3,240
0.3% 84
2016
Q3
$340K Hold
3,240
0.28% 99
2016
Q2
$320K Sell
3,240
-100
-3% -$10.3K 0.3% 98
2016
Q1
$334K Sell
3,340
-50
-1% -$5.15K 0.36% 84
2015
Q4
$406K Hold
3,390
0.46% 66
2015
Q3
$412K Hold
3,390
0.44% 66
2015
Q2
$415K Sell
3,390
-200
-6% -$22.9K 0.43% 71
2015
Q1
$397K Hold
3,590
0.41% 74
2014
Q4
$426K Buy
+3,590
New +$379K 0.43% 70

Other funds holding CELG

Diligent Investors's CELG Position: Q3 2019 in Review

Diligent Investors sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 3,615 shares — an estimated $334K sold.

Diligent Investors first reported a position in CELG in Q4 2014 and held it in 19 quarters. The position peaked at $472K in Q3 2017. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Diligent Investors reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Diligent Investors sold 3,615 Celgene Corp shares in Q3 2019, an estimated $334K.
  • Diligent Investors first reported a position in Celgene Corp in Q4 2014 and held it in 19 quarters.
  • Diligent Investors's Celgene Corp position peaked at $472K in Q3 2017.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Diligent Investors's 13F filing for Q3 2019, filed 22 Oct 2019.